GlassScriptPhysician profile
Jonathan D Ballard
NPI 1881150100
$2,938.92
in general payments reported to CMS, 2019-2025
23 companies · $20.33 in 2025
The $20.33 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $375 · 2023: $1,147 · 2024: $1,396 · 2025: $20.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,563.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $757.04 | 2022-2025 | |
| Lilly USA, LLC | $349.84 | 2022-2024 | Mounjaro, Jardiance, Trulicity |
| Astrazeneca Pharmaceuticals LP | $269.85 | 2022-2024 | Breztri, Airsupra |
| Axsome Therapeutics, INC. | $251.71 | 2023-2024 | Auvelity |
| Novo Nordisk INC | $232.27 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.05 | 2022-2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $144.90 | 2022-2024 | Xifaxan, Trulance |
| Otsuka America Pharmaceutical, INC. | $131.54 | 2022-2024 | Rexulti, Abilify Maintena |
| Amgen INC. | $114.26 | 2023-2024 | Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $97.79 | 2022-2024 | |
| Gilead Sciences, INC. | $91.21 | 2023 | Epclusa |
| Glaxosmithkline, LLC. | $57.41 | 2023-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Mylan Specialty L.P. | $57.02 | 2023 | Yupelri |
| Phathom Pharmaceuticals, INC. | $56.43 | 2023-2024 | Voquezna |
| Neurocrine Biosciences, INC. | $32.80 | 2023 | Ingrezza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $30.90 | 2022-2024 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $20.10 | 2024 | Inspire |
| Merck Sharp & Dohme LLC | $18.23 | 2024 | Gardasil 9, Capvaxive, Gardasil |
| Exact Sciences Corporation | $18.14 | 2024 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $15.47 | 2024 | Austedo Xr |
| Hologic Sales and Service, LLC | $13.84 | 2024 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $13.12 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Ballard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.